Biotech Alert: Searches spiking for these stocks today
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
Geron price target lowered to $4 from $6 at Scotiabank
Scotiabank lowered the firm’s price target on Geron (GERN) to $4 from $6 and keeps an Outperform rating on the shares. While the company’s Q4 ...
Geron Corp (GERN) Q4 2024 Earnings Call Highlights: Strong Cash Position and Rytelo's FDA ...
Geron Corp (GERN) reports a robust cash reserve and key FDA approval for Rytelo, but faces flat revenue trends and leadership changes in its commercial strategy.
Why Geron Stock Is Plummeting Today
Geron (NASDAQ: GERN) stock is getting crushed in Wednesday's trading. Geron stock is seeing huge sell-offs on the heels of ...
Geron Shares Drop After Wider-Than-Expected 4Q Loss
Geron shares fell 30% to $1.66 after the company reported a fourth-quarter loss that was wider than expected.
Geron: Rytelo's Market Share Concerns Justified As 3L Dominates Early Sales
Geron Corporation's stock dropped 50% before its Q4 2024 earnings report, with Rytelo's revenue close to projections but new ...
Investing2d
Geron stock tumbles on disappointing guidance
Geron ended 2024 with a strong cash position and reported that revenues for the third and fourth quarters exceeded expectations. The company’s net product revenue for RYTELO reached $47.5 million in ...
Geron stock plunges 30% amid Rytelo sales concerns (update)
Geron (NASDAQ:GERN) stock plunged 30% after management reportedly indicated on the company's Q4 earnings call that sales of ...